fumonisin-b1 and Prostatic-Neoplasms

fumonisin-b1 has been researched along with Prostatic-Neoplasms* in 3 studies

Other Studies

3 other study(ies) available for fumonisin-b1 and Prostatic-Neoplasms

ArticleYear
Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis.
    Journal of cellular physiology, 2010, Volume: 222, Issue:3

    Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24) uniquely displays broad cancer-specific apoptosis-inducing activity through induction of endoplasmic reticulum (ER) stress. We hypothesize that ceramide, a promoter of apoptosis, might contribute to mda-7/IL-24 induction of apoptosis. Ad.mda-7-infected tumor cells, but not normal cells, showed increased ceramide accumulation. Infection with Ad.mda-7 induced a marked increase in various ceramides (C16, C24, C24:1) selectively in prostate cancer cells. Inhibiting the enzyme serine palmitoyltransferase (SPT) using the potent SPT inhibitor myriocin (ISP1), impaired mda-7/IL-24-induced apoptosis and ceramide production, suggesting that ceramide formation caused by Ad.mda-7 occurs through de novo synthesis of ceramide and that ceramide is required for mda-7/IL-24-induced cell death. Fumonisin B1 (FB1) elevated ceramide formation as well as apoptosis induced by Ad.mda-7, suggesting that ceramide formation may also occur through the salvage pathway. Additionally, Ad.mda-7 infection enhanced expression of acid sphingomyelinase (ASMase) with a concomitant increase in ASMase activity and decreased sphingomyelin in cancer cells. ASMase silencing by RNA interference inhibited the decreased cell viability and ceramide formation after Ad.mda-7 infection. Ad.mda-7 activated protein phosphatase 2A (PP2A) and promoted dephosphorylation of the anti-apoptotic molecule BCL-2, a downstream ceramide-mediated pathway of mda-7/IL-24 action. Pretreatment of cells with FB1 or ISP-1 abolished the induction of ER stress markers (BiP/GRP78, GADD153 and pospho-eIF2alpha) triggered by Ad.mda-7 infection indicating that ceramide mediates ER stress induction by Ad.mda-7. Additionally, recombinant MDA-7/IL-24 protein induced cancer-specific production of ceramide. These studies define ceramide as a key mediator of an ER stress pathway that may underlie mda-7/IL-24 induction of cancer-specific killing.

    Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Survival; Ceramides; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fumonisins; Humans; Interleukins; Male; Phosphorylation; Prostatic Neoplasms; Protein Phosphatase 2; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; RNA Interference; Serine C-Palmitoyltransferase; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingomyelins; Stress, Physiological; Time Factors; Transduction, Genetic; Up-Regulation

2010
Ceramide accumulation is independent of camptothecin-induced apoptosis in prostate cancer LNCaP cells.
    Biochemical and biophysical research communications, 2002, Jun-07, Volume: 294, Issue:2

    We have investigated to determine the source of ceramide produced during the genotoxic apoptosis induced by the anti-cancer drug, camptothecin (CPT), in human prostate cancer LNCaP cells by measuring the activities of acid and neutral sphingomyelinases (SMase) and by using fumonisinB(1) (FB(1)), the inhibitor of ceramide synthase involving de novo synthesis of ceramide. In contrast to time-dependent elevation of intracellular ceramide level after CPT-treatment, the activities of both SMases were not increased but rather decreased. Instead, pretreatment for 3 h with FB(1) (100 microM), an inhibitor of ceramide synthase, almost completely abrogated ceramide accumulation observed in cells exposed to CPT for 18 h. These results indicate that ceramide is produced via de novo pathway but not via sphingomyelin hydrolysis pathway. Furthermore, it is to be noted that the pretreatment with FB(1) did not affect the CPT-induced apoptosis as assessed by DNA ladder formation, Hoechst 33342 staining, flow cytometry, and mitochondrial potential thereby leading us to propose that ceramide accumulation is independent of apoptosis in this system.

    Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Camptothecin; Carboxylic Acids; Caspases; Ceramides; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Fumonisins; Humans; Male; Oxidoreductases; Prostatic Neoplasms; Sphingomyelin Phosphodiesterase; Sphingomyelins; Tumor Cells, Cultured

2002
Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy.
    Cancer research, 1999, Nov-15, Volume: 59, Issue:22

    Activation of the apoptosis program has been implicated in the response of cancer cells to chemotherapy. Therefore, we postulated that chemotherapy-resistant prostate cancer has developed a lesion in the apoptosis signal transduction cascade. In this study, we investigated the mechanism underlying the resistance of apoptosis-insensitive prostate cancer cells to apoptosis. We approached this by comparing the response of the androgen-sensitive LNCaP cell line and the androgen-insensitive PC3 cell line to treatment with the topoisomerase I inhibitor, camptothecin. We demonstrated that LNCaP cells are susceptible to camptothecin-induced cell death, and PC3 cells are resistant. Additional studies confirmed that the mode of cell death in the LNCaP cells was by apoptosis. We then determined that a component of the resistance to death in the apoptosis-insensitive cells involved a defect in the generation of ceramide, a key lipid mediator of apoptosis. Specifically, we demonstrated that PC3 cells are unable to elevate ceramide in response to treatment with camptothecin. In contrast, elevations in ceramide levels occur in LNCaP cells in response to the same treatment. Significantly, additional studies showed that treatment with exogenous ceramide overcomes the lesion in the PC3 cells and induces apoptosis. In attempting to gain preliminary insight into the nature of the lesion in ceramide formation in the apoptosis-resistant cells, we established that generation of ceramide in LNCaP cells is independent of the de novo pathway. These studies present novel insights into the mechanism by which prostate cancer cells may be resistant to induction of apoptosis. The significance of this study lies in the fact that an understanding of the biological and molecular events contributing to the resistance of prostate cancer to therapy is crucial to the development of more effective regimens for advanced disease.

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carboxylic Acids; Ceramides; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fumonisins; Humans; Male; Molecular Weight; Neoplasm Proteins; Oxidoreductases; Prostatic Neoplasms; Proteins; Tumor Cells, Cultured

1999